Instructions
Write-ups should be a maximum of two text pages (not counting a cover page if you
wish to use one) typed and double-spaced with one-inch margins. You may use
whatever style/s and size/s of font you believe compatible with a memo to a senior manager
or potential investor. You will forfeit your grade for the write-up if reading it is
physically difficult. Feel free to use bullet points. You may attach as many numerical
calculations, tables, graphs or diagrams as you wish in an appendix. However, poorly
labeled, hard to follow exhibits and/or those that do not support a point in your text (i.e.
volumetric padding) may end up reducing your grade. All appropriate citations should be
made, but can be included in the appendix if you desire.
You will be evaluated on how well you address the question/s assigned. I will look for
concise, clear, systematic and logical arguments based on any relevant analytic tools you
wish to utilize. You are not confined to those tools, concepts etc mentioned in this course,
but not using any of them will be potentially problematic.
Questions to Answer – Case Assignment: Kendle International
- How does the CRO business work? How is Kendle doing?
- What strategic choices does Kendle face? Can it survive as a privately owned domestic company or does it need to become a much bigger firm with operations outside the US?
- Should Candace Kendle and Christopher Bergen consider selling their firm to another company in early 1997?
- How does the potential sales price of the firm compare to its underlying economic value as a stand-alone firm?
- Do the acquisitions of U-Gene and gmi make sense? Are the proposed deals priced fairly?
- What strategy would you recommend? Proceed with both acquisitions now or do one followed by an initial public offering (IPO) and the second acquisition later?
